Vinay Prasad leaves FDA apparently due to backlash from the agency's handling of potential deaths related to Sarepta's ...

Now, it’s worth noting Stock Advisor's total average return is 1,039% — a market-crushing outperformance compared to 182% for ...

The country is one of the most exposed in Europe to Trump’s tariffs, intensifying fears that a golden era of growth will slow down ...

In the wake of Trump’s global trade war, can the World Trade Organization reclaim its role as guardian of free trade?

AstraZeneca’s CEO said the company has proposed U.S. price cuts to some drugs, while Doximity enters competitive AI scribing ...

The presence of George Osborne at Robey Warshaw, and the payouts to partners following the £146m sale to Evercore, is certain ...

The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...

When Tidmarsh was appointed to CDER, the FDA emphasised his academic and clinical credentials – including his role as ...

Dr. Susan Monarez is slated to be sworn in as director of the U.S. Centers for Disease Control and Prevention on Thursday, a ...

The future is bright for corporate tax dodgers. While the rest of the world is working together on a plan to crackdown on big ...

The Senate confirmed Susan Monarez as director of the Centers for Disease Control and Prevention on Tuesday evening.

Vinay Prasad, the top vaccine regulator and chief scientific officer at the Food and Drug Administration (FDA) and a critic of the agency’s COVID-19 policies, has departed after being on the job ...